Daniel Stegman
Ophthalmology · Clifton, NJNPI 1740251040
Payments from drug & device makers
Across 178 payments — averaging $37.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Aerin Medical Inc.$4K
- AbbVie$1K
- Alcon$532
- NEW World Medical,inc.$265
- Biotissue Holdings Inc.$160
- Gilead$125
- plus $742 from 18 others
What the payments were for
- Consulting fees$3,68855%
- Food & beverage$3,06145%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Aerin Medical Inc. | 7 | $3,688 |
| AbbVie(2 entities) | 87 | $1,237 |
| Alcon | 38 | $532 |
| NEW World Medical,inc. | 2 | $265 |
| Biotissue Holdings Inc. | 8 | $160 |
| Gilead | 1 | $125 |
| Rxsight Inc | 1 | $109 |
| Acclarent, Inc | 1 | $104 |
| Eyevance Pharmaceuticals LLC | 6 | $101 |
| Novartis | 7 | $95 |
| Bausch & Lomb Americas Inc. | 5 | $71 |
| Oyster Point Pharma, Inc. | 3 | $45 |
| Ivantis, Inc | 1 | $45 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $19 |
| Tarsus Pharmaceuticals, Inc. | 1 | $19 |
| Dompe US, Inc. | 1 | $17 |
| Ocular Therapeutix, Inc. | 1 | $17 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $15 |
| Mallinckrodt Hospital Products Inc. | 1 | $15 |
| Mallinckrodt Enterprises LLC | 1 | $15 |
| Aerie Pharmaceuticals, Inc. | 1 | $15 |
| Shire North American Group Inc | 1 | $14 |
| Genentech USA, Inc. | 1 | $14 |
| Genentech, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VIVAER STYLUS$3,688
- Kahook Dual Blade$203
- Clearpath$203
- Ahmed Glaucoma Valve$203
- Streamline$203
- Precision 1$132
- Epclusa$125
- LUMIGAN$125
- DURYSTA$118
- RXSIGHT CONTACT LENS$109
- RXSIGHT INJECTOR CARTRIDGE$109
- RXSIGHT INJECTOR HANDPIECE$109
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$109
- LIGHT ADJUSTABLE LENS (LAL)$109
- Acclarent Navwire$104
- Acclarent Aera$104
How this compares
$6,749 in reported general payments places this provider in the 85th percentile of 583 ophthalmology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| LumiganBimatoprost | 193 | $103,555 |
| RestasisCyclosporine | 28 | $24,791 |
| XiidraLifitegrast | 29 | $22,197 |
| CombiganBrimonidine Tartrate/Timolol | 35 | $15,540 |
| MieboPerfluorohexyloctane/Pf | 11 | $7,889 |
| Latanoprost | 825 | $5,055 |
| Brimonidine Tartrate-TimololBrimonidine Tartrate/Timolol | 37 | $3,840 |
| Brimonidine Tartrate | 64 | $3,457 |
| Travoprost | 36 | $3,377 |
| Timolol Maleate | 372 | $3,273 |
| Tobramycin-DexamethasoneTobramycin/Dexamethasone | 53 | $1,877 |
| Prednisolone Acetate | 58 | $1,489 |
| Fluorometholone | 17 | $992 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 60 | $741 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 49 | $494 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieLumigan, Restasis, Combigan | $1,237 | $143,886256 claims |
| Bausch & Lomb Americas Inc.Xiidra, Miebo | $71 | $30,08740 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 583 ophthalmology providers in New Jersey.
Other ophthalmology in Clifton
- Patrick HigginsBloomfield$16.7M
- Jai ParekhWoodland Park$2.1M
- Eric MannDover$860K
- Sharad MansukaniMoorestown$744K
- Ravi PatelEatontown$729K
- Luis Gonzalez GonzalezTeaneck$727K
- Cynthia MatossianPennington$726K
- Charles CraneSouth Orange$582K
- Albert KhouriNewark$542K
- Brett BieloryRutherford$477K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.